Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in elderly patients with myelodysplastic syndrome
ChiCTR1800020355Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in myelodysplastic syndrome (MDS), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoint: Blood routine. Started Jan 2019; status: recruiting.
02
Drugs
sirolimus
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on ChiCTR1800020355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020355.